Call for Abstract

International Conference on Oncology Nursing, Cancer Care & Radiology and Imaging , will be organized around the theme “Inspiring Innovations and Advanced Practice in Cancer Care ”

Oncology Nursing 2016 is comprised of 21 tracks and 133 sessions designed to offer comprehensive sessions that address current issues in Oncology Nursing 2016.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

Oncology has become one of the major focus areas for pharmaceutical and biotechnology companies because of the high unmet need for improved treatments for multiple types of cancer.For an oncologist or an oncology nurse, finding the appropriate words to comfort a family who is facing the loss of a loved one can be difficult. This section addresses how different groups—oncologists, patients, and Nurses—think about end-of-life care issues. This section discusses an oncologist's responsibility and perspective when it comes to difficult subjects such as advanced cancer, hospice, do not resuscitate orders, cytotoxic therapy, supportive care, maintaining a patient's dignity, and imminent death. Articles in this series also discuss the role of spirituality and religion at the time of death, and the importance of good communication between the oncologist and family members throughout the dying process.For More Information please, CLICK HERE

  • Track 1-1Clinical implications and Oncology Nursing Practice
  • Track 1-2Primary Care and Oncology Nursing
  • Track 1-3Oncology Nursing and Cancer care
  • Track 1-4Psychological and psychosocial aspects and Cancer care
  • Track 1-5Effects of Cancer in chemotherapy and Oncology Nursing
  • Track 1-6Oncology Nursing in USA

Oncology nurses practice in a variety of settings including acute care hospitals, ambulatory care clinics, private oncologists' offices, radiation therapy facilities, home healthcare agencies, and community agencies. The roles of the oncology nurses vary from the intensive care focus of bone marrow transplantation to the community focus of cancer screening, detection, and prevention. Health promotion includes motivating people to embrace behaviors that both improve their emotional and physical quality of life and reduce their risk for premature morbidity and mortality. Although the majority of adults treated for cancer in the United States live free of disease for many years, many survivors experience lasting side effects and complications of treatment. Others encounter recurrences or new cancers that require additional treatment. Late effects vary from one cancer survivor to the next. They can range from very mild to serious. Medical experts can’t always predict if or when they will occur. Some effects might improve or go away with time such as anemia. Patients with advanced cancer are willing to pay more for all aspects of a good end-of-life experience compared with healthy older adults. Both groups are willing to pay more to be pain free and to die at home. This Session Includes Track Cancer Genetics: Genetic Counseling, Ethical Issues, and the Nurse’s Role, Health Promotion, Late Effects of Cancer Treatment and Long-Term Survivorship Issues,End-of-Life Issues, Psychological and Family Issues, Nursing-Sensitive Patient Outcomes, Translation Science, Cancer Epidemiology, Palliative Care.For More Information please, CLICK HERE

  • Track 2-1Health Promotion
  • Track 2-2Late Effects of Cancer Treatment and Long-Term Survivorship Issues
  • Track 2-3End-of-Life Issues
  • Track 2-4Psychological and Family Issues
  • Track 2-5Nursing-Sensitive Patient Outcomes
  • Track 2-6Translation Science
  • Track 2-7Cancer Epidemiology
  • Track 2-8Cancer Genetics: Genetic Counseling, Ethical Issues, and the Nurse’s Role
  • Track 2-9Palliative Care

Organ/Tumor Specific Cancers are cancers named basing on the location of cancer in the body organ. Cancer can affect just about every organ in the human body. Each type of cancer is unique with its own causes, symptoms, and methods of treatment. Lung cancer was the most common cancer worldwide in men contributing nearly 17% of the total number of new cases diagnosed in 2012 and became an important topic for World Cancer Conferences. The top three, lung, prostate and colorectal cancers, contributed nearly 42% of all cancers (excluding non-melanoma skin cancer).There are more than 200 different types of cancer, but Breast cancer, Head & Neck Cancer, Blood, lung and leukemia cancer cancers that are diagnosed with the greatest frequency.  Lung cancer, also known as carcinoma of the lung or pulmonary carcinoma, is a malignant lung tumor characterized by uncontrolled cell growth in tissues of the lung. Cancer genetics is now one of the fastest expanding medical specialties. However, some people inherit mutation in the germ line. The mutations occur in two classes of cellular genes: oncogenes and tumor suppressor genes.This Session Includes Head and neck cancers, Gastrointestinal cancers, Lung Cancer, Colorectal Cancer, Melanoma, Hematologic cancers, Robotics in oncological Surgery, Translational approach in cancer treatment.For More Information please, CLICK HERE

  • Track 3-1Head and neck cancers
  • Track 3-2Gastrointestinal cancers
  • Track 3-3Translational approach in cancer treatment
  • Track 3-4Lung Cancer
  • Track 3-5Colorectal Cancer
  • Track 3-6Melanoma
  • Track 3-7Hematologic Oncology

Breast Cancer is the most common cause of death in women. We first need to understand how cancer develops in the body for reducing breast cancer risk.  Current understanding of the biology of breast cancer is very important and its relevance to treating and preventing the disease. Breast cancer is not a one disease. For example, understanding that breast tissue of girls and young women is especially sensitive to cancer causing agents can help direct risk reduction efforts to these groups. Making sense of cancer denotes taking a step toward more apprised decisions about our bodies, ourselves and our environment.This Session Includes Biology of Breast CancerRole of Nurse in Breast Cancer Care, Breast Cancer Treatment Side Effects, Innovative Therapeutic Approaches, Optimal Breast Cancer Pathology – Organisation.For More Information please, CLICK HERE

  • Track 4-1Biology of Breast Cancer
  • Track 4-2Role of Nurse In Breast Cancer Care
  • Track 4-3Breast Cancer Treatment Side Effects
  • Track 4-4Innovative Therapeutic Approaches
  • Track 4-5Optimal Breast Cancer Pathology – Organisation

It can be frightening to hear that a child has cancer or a blood disorder. It is acknowledged that Neuroblastoma is the most common extracranial solid tumor of infancy. It is an embryonal malignancy of the sympathetic nervous system arising from neuroblasts (pluripotent sympathetic cells). Researchers are looking for genetic source of childhood brain tumors. Their main target is Germ cell tumors (GCTs) in children which are masses of tissue formed by the type of immature cells. Germ cell tumors may be malignant, which means cancerous, or they may be benign, which means noncancerous. The common blood disorders in children are leukemia and lymphoma. Leukemia is a disease of the white blood cells. The most common type of pediatric leukemia is acute lymphocytic leukemia. Other types of leukemia that occur less frequently in children are acute myeloid leukemia, and chronic myeloid leukemia. Lymphomas (Hodgkin and non-Hodgkin lymphoma) are the third most common cancer in children. Based on the characteristics and microscopic appearance of the cancer cell, the pediatric lymphomas are divided into Hodgkin Lymphoma and non-Hodgkin lymphoma.This Session Includes Pediatric Brain Tumor Models, Neurocutaneous Disorders, Neurofibromatosis, Primitive neuroectodermal tumor, Leukemia, Epigenetics in Pediatric Cancers, Pediatric Neurobiology and  Proton Radiotherapy for Pediatric Brain Tumors.For More Information please, CLICK HERE

  • Track 5-1Psychosocial Care of Pediatric Oncology
  • Track 5-2Neurocutaneous Disorders
  • Track 5-3Management of side effects from surgery, chemotherapy, and radiation
  • Track 5-4Primitive neuroectodermal tumor
  • Track 5-5Leukemia
  • Track 5-6Epigenetics in Pediatric Cancers
  • Track 5-7Pediatric Neurobiology
  • Track 5-8Proton Radiotherapy for Pediatric Brain Tumors
  • Track 5-9Emerging Therapies in Pediatric Oncology

Surgical Oncology Nursing provides you with a detailed examination of surgical patients with cancer from diagnosis to survivorship. Caring for surgical patients with cancer involves a diverse healthcare team with many hands touching patients at different stages. In today's changing climate, oncology nurses work much more closely with a diverse team of healthcare professionals and having an intimate knowledge of surgical patients with cancer and the treatment process has become even more important. This Session Includes Preoperative Care of Patient with Cancer, Surgical Care of Breast Cancer, Surgical Care of Brain Tumors, Robotics in Oncological Surgery, Reconstructive Surgery, Survivorship Issues in Surgical Oncology Nursing.For More Information please, CLICK HERE

  • Track 6-1Preoperative Care of Patient with Cancer
  • Track 6-2Surgical Care of Breast Cancer
  • Track 6-3Surgical Care of Brain Tumors
  • Track 6-4Robotics in Oncological Surgery
  • Track 6-5Reconstructive Surgery
  • Track 6-6Survivorship Issues in Surgical Oncology Nursing

Gynecologic oncology is the field of medicine that focuses on cancers of the female generative system, including vaginal cancer, ovarian cancer, cervical cancer,uterine cancer. As experts they have wide training in the diagnosis and treatment of these cancers.

In 2012, there were about 4.7 million cases of women cancer worldwide in which 54% cases arose in less developed countries. Gynecologic cancers, with cancer of the vulva, vagina, endometrium, ovary, placenta and adnexa, accounted for 9% of all female major tumours worldwide and 45% of all genital cancers.Although the occurrence and mortality from endometrial and ovarian cancer are major, other cancers are very uncommon. Primary cancers of the vulva, vagina, placenta and adnexa total 0.6% of all woman cancers.Endocrine oncology refers to a medical speciality dealing with hormone producing tumors, i.e. a combination of endocrinology and oncology.This Session Includes Organ Specific Gynecologic Cancers, Endocrine tumor syndromes, Endocrine tumor syndromes, Gastrointestinal & Pulmonary Endocrine Tumors, Endocrine Pancreatic Tumors.For More Information please, CLICK HERE

  • Track 7-1Gastrointestinal & Pulmonary Endocrine Tumors
  • Track 7-2Endocrine Pancreatic Tumors
  • Track 7-3Endocrine Tumor Syndromes
  • Track 7-4Organ Specific Gynecologic Cancers

The majority of people with cancer will experience pain at some time or another. The pain can result from the cancer itself, or from the cancer's treatment. In addition, some people who have been cured of their cancer can continue to suffer from pain.

Cancer pain, or the discomfort that stems from cancer and its treatment, can be controlled most of the time,in which a nurse plays a important role. There are many different medicines and methods available to control cancer pain. People who have cancer and are feeling pain need to inform their doctor immediately. The earlier pain treatment is started, the more effective it may be. Comprehensive pain assessment is one of the most important initial steps for successful management of cancer pain.This Session includes Treating Cancer Pain, Non-Drug Pain Treatment,Chemotherapy in Cancer Pain and Pain-relieving therapies.For More Information please, CLICK HERE

  • Track 8-1Treating Cancer Pain
  • Track 8-2Non-Drug Pain Treatment
  • Track 8-3Pain-relieving therapies
  • Track 8-4Chemotherapy in Cancer Pain

Complementary and alternative medicine (CAM) is the term for medical products and practices that are not part of standard medical care.

Some CAM therapies have undergone careful evaluation and have found to be safe and effective. However there are others that have been found to be ineffective or possibly harmful. Less is known about many CAM therapies, and research has been slower for a number of reasons:

Time and funding issues, Problems finding institutions and cancer researchers to work with on the studies and Regulatory issues

CAM therapies need to be evaluated with the same long and careful research process used to evaluate standard treatments. Standard cancer treatments have generally been studied for safety and effectiveness through an intense scientific process that includes clinical trials with large numbers of patients.This Session Includes Alternative Medical Systems, Mind-Body Methods, Nutritional Methods, Pharmacologic and Biologic Treatments.For More Information please, CLICK HERE

  • Track 9-1Alternative Medical Systems
  • Track 9-2Mind-Body Methods
  • Track 9-3Nutritional Methods
  • Track 9-4Pharmacologic and Biologic Treatments

A cancer diagnosis and its treatment can be overwhelming. Usually patients and family members have many questions and concerns about the disease and the treatment. The supportive care program helps patients and family members deal with the physical and emotional distress caused by the cancer diagnosis and treatment. The less distress patients have, the more energy they can direct toward recovery.

Comprehensive supportive care services require the expertise of an interdisciplinary team in order to adequately assess and treat the complex needs of cancer patients and their families.This Session Includes Art therapy, Child psychiatry, Music Therapy, Nutrition & Supplements, Physical, occupational, & speech therapies, Parent link program, Social work, Cancer Prehabilitation & Rehabilitation, Diet and exercise and Spiritual Counseling.For More Information please, CLICK HERE

  • Track 10-1Art therapy
  • Track 10-2Child psychiatry
  • Track 10-3Nutrition & Supplements
  • Track 10-4Physical, occupational, & speech therapies
  • Track 10-5Parent link program
  • Track 10-6Social work
  • Track 10-7Cancer Prehabilitation & Rehabilitation
  • Track 10-8Diet and exercise

Molecular Cancer Therapeutics will focus on basic research that has implications for cancer therapeutics in the following areas: Experimental Cancer. Despite the fact that new technologies and strategies often fail to identify well-established cancer biomarkers and show a bias toward the identification of high-abundance molecules, these technological advances have the capacity to revolutionize biomarker discovery.  Cancer immunotherapy (immuno-oncology) is the use of the immune system to treat cancer .The study of the tumor metabolism, also known as tumor metabolome describes the different characteristic metabolic changes in tumor cells. The emerging field of metabolomics – which attempts to profile all metabolites within a cell or biological system – is now being used to analyze cancer metabolism on a system-wide scale, painting a broad picture of the altered pathways and their interactions with each other. While a large fraction of cancer metabolomics research is focused on finding diagnostic biomarkers, metabolomics is also being used to obtain more fundamental mechanistic insight into cancer and carcinogenesis.This Session Includes Current Trends and Innovations in Metabolomics, Molecular cancer therapeutics, Clinical and potential applications of metabolomics in oncology, Metabolomics in novel biomarker discovery, Revisiting tumor metabolism, Telomerase: A target for cancer therapeutics, Analytical and bio-analytical techniques in metabolomics, Transcriptomics, Toxicology and drug metabolism.For More Information please, CLICK HERE

  • Track 11-1Current Trends and Innovations in Metabolomics
  • Track 11-2Molecular cancer therapeutics
  • Track 11-3Clinical and potential applications of metabolomics in oncology
  • Track 11-4Metabolomics in novel biomarker discovery
  • Track 11-5Revisiting tumor metabolism
  • Track 11-6Telomerase: A target for cancer therapeutics
  • Track 11-7Analytical and bio-analytical techniques in metabolomics
  • Track 11-8Transcriptomics
  • Track 11-9Toxicology and drug metabolism

Companion Diagnostics market has been segmented geographically into North America, Europe, Asia Pacific and LAMEA. North America has the major market share of 43.97% followed by Europe, which accounted for about 38% of the overall CD market in 2013. North America and Europe together accounted for over 82% in the global CD market in 2013 and they would continue to be the major markets through 2020. This is mainly due to the increasing incidence of cancer and other diseases and higher health care awareness in these regions.Companion diagnostics is segmented on the basis of its use for indications such as oncology, cardiovascular conditions, central nervous system indications, inflammation and virology. Oncology is the highest revenue generating segment, as majority of the companion diagnostics have been developed for detection of various cancer biomarkers. The key driver for this market is an increase in research and development of targeted drugs, which require a corresponding companion diagnostic.This Session Includes Cancer screening and early detection & prevention, Molecular diagnostics, Digital cancer pathology and imaging, Personalized genomics and clinical biomarkers, Diffuse optical imaging, Magnetic resonance imaging, Positron emission tomography, Computed tomography, Structural and functional imaging, Radioactive compounds in Neuroimaging, Biomarker Discovery.For More Information please, CLICK HERE

  • Track 12-1Cancer screening and early detection & prevention
  • Track 12-2Radioactive compounds in NeuroImaging
  • Track 12-3Structural and functional imaging
  • Track 12-4Computed tomography
  • Track 12-5Positron emission tomography
  • Track 12-6Magnetic resonance imaging
  • Track 12-7Diffuse optical imaging
  • Track 12-8Personalized genomics and clinical biomarkers
  • Track 12-9Digital cancer pathology and imaging
  • Track 12-10Molecular diagnostics
  • Track 12-11Biomarker Discovery

The scope of this study entails the current immunology therapeutics markets for several of the most common cancers. The sectors covered are colony stimulating factors (CSFs), interferon alfa and gamma products, interleukin products and therapeutic monoclonal antibodies, including antibody conjugates, cancer vaccines and other cancer treatment immunology products. Vaccines against HPV and hepatitis B are included; while such vaccines act only indirectly against cancer, they do serve to protect against the disease. Also covered is oncolytic virology, so new that its market tables have been presented separately from the immunotherapy tables. The report also includes discussion of the regulatory environment, current and developing technologies, cancer incidence, market projections and market share, along with latest trends and clinical trials. Stem cell transplant (also called peripheral blood stem cell transplant) is a treatment to try to cure some types of cancer, such as leukaemia, lymphoma and myeloma. You have very high doses of chemotherapy, sometimes with whole body radiotherapy.This Session Includes Stem cell mediated immuno gene therapy for tumors, Challenges and new opportunities with antibody drugs, Tumour-host interactions, nuclear responses and tumorigenesis, Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers, Cancer-induced immunosuppressive cells, Immune system stimulation, Acquired resistance.For More Information please, CLICK HERE

  • Track 13-1Stem cell mediated immuno gene therapy for tumors
  • Track 13-2Challenges and new opportunities with antibody drugs
  • Track 13-3Tumour-host interactions, nuclear responses and tumorigenesis
  • Track 13-4Cancer biomarkers, Diagnostic and Prognostic Cancer Biomarkers
  • Track 13-5Cancer-induced immunosuppressive cells.
  • Track 13-6Immune system stimulation
  • Track 13-7Acquired resistance

The landscape of Cancer treatment has dramatically changed over the last four decades. The age when surgery and radiotherapy were the only effective way to fight tumour growth has ended. A complex scenario where the molecular features of tumours seem to be the cornerstone of any therapy is now emerging. Here we provide an overview on the different approaches to cancer treatment. This will help the reader to acknowledge the pivotal role of some classic cancer therapies, including surgery, radiation, chemotherapy and endocrine therapy, now better understood in the mechanisms underpinning their efficacy. Following, we focus on the understanding of the value of systemic treatment and on an up-date on the novel, up-coming therapies of the current targeted therapy age, including new antibodies, small molecules, antiangiogenics and viral therapy. We briefly elaborate, finally, on new biomarkers development and how it should rule and determine the future of therapeutic research in cancer.This Session Includes Radiotherapy and chemotherapy, Molecular-targeted therapies, Cancer: Gene expression and protein profiling; Surgery and laparoscopy, Hormone replacement therapy, Cancer Metabolism, Latest drug developments in Neuro oncology, Innovational combinational therapies.For More Information please, CLICK HERE

  • Track 14-1Molecular-targeted therapies
  • Track 14-2Cancer: Gene expression and protein profiling; Surgery and laparoscopy
  • Track 14-3Hormone replacement therapy
  • Track 14-4Cancer Metabolism
  • Track 14-5Latest drug developments in Neuro oncology
  • Track 14-6Innovational combinational therapies

Anti-cancer monoclonal antibodies can be targeted against malignant cells by several mechanisms. Tissue-specific gene delivery using immune liposomes has also been achieved in brain, and breast cancer tissue. Antibody-directed enzyme pro drug therapy involves the application of cancer associated monoclonal antibodies which are linked to a drug-activating enzyme. Subsequent systemic administration of a non-toxic agent results in its conversion to a toxic drug, and resulting in a cytotoxic effect which can be targeted at malignant cells. A cancer vaccine is a vaccine that either treats existing cancer or prevents development of a cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines. There are currently no vaccines able to prevent all cancers. However vaccines against some oncoviruses have proven extremely effective. Treatment often fails when cancer becomes resistant to anti-cancer drugs. Knowledge of all the human genes and their functions may allow effective preventive measures, and change drug research strategy and drug discovery development processes.This Session Includes Functional genomics in drug discovery and development, Therapeutic antibodies and cancer vaccines, Novel drug delivery system and cancer drug designing, Anticancer drugs in global market: economy and their cost effectiveness, Nanotechnology in cancer drugs, Cancer clinical trials, Regulatory issues in cancer research, Drug compounds targeting Tumor metabolism, CAR T-Cell Therapy, Oncolytic viral therapiesGene-therapy, Adoptive T-Cell transfer.For More Information please, CLICK HERE

  • Track 15-1Functional genomics in drug discovery and development
  • Track 15-2Gene-therapy
  • Track 15-3Oncolytic viral therapies
  • Track 15-4CAR T-Cell Therapy
  • Track 15-5Drug compounds targeting Tumor metabolism
  • Track 15-6Regulatory issues in cancer research
  • Track 15-7Cancer clinical trails
  • Track 15-8Nanotechnology in cancer drugs
  • Track 15-9Anticancer drugs in global market: economy and their cost effectiveness
  • Track 15-10Novel drug delivery system and cancer drug designing
  • Track 15-11Therapeutic antibodies and cancer vaccines
  • Track 15-12Adoptive T-Cell transfer

Prognosis is the outlook or the chance of recovery from cancer. New and better treatments are helping people diagnosed with breast cancer live longer than ever before. Cancer survival rates or survival statistics tell you the percentage of people who survive a certain type of cancer for a specific amount of time. Cancer statistics often use an overall five-year survival rate.

Oncology Cancer survival rates are supported on research from information gathered on hundreds or thousands of individuals with a particular cancer. An overall survival rate includes individuals of all ages and health conditions who have been diagnosed together with your cancer, together with those diagnosed terribly early and people diagnosed terribly late.This Session Includes Liver Cancer prognosis, Brain Cancer prognosisSquamous cell Cancer prognosis and Metastatic prognosis.For More Information please, CLICK HERE

  • Track 16-1Liver Cancer prognosis
  • Track 16-2Brain Cancer prognosis
  • Track 16-3Squamous cell Cancer prognosis
  • Track 16-4Metastatic prognosis

Cancer Cell Biology, Diagnosis and Applied Research are using cell biological and other methods to investigate the mechanisms that regulate cell proliferation and differentiation. This is an approach applied to understanding basic cell physiology, cancer biology and the pathogenesis of infectious diseases. There is different area of research within the Research Theme. There is considerable interaction between individual laboratories in those areas. Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, the ability to give rise to all cell types found in a particular cancer sample.  The process by which cancer cells spread to other parts of the body is also called metastasis. Virtually all cancers, including cancers of the blood and the lymphatic system, can form metastatic tumors. The metastasis of blood and lymphatic system cancers to the lung, central nervous system, heart and other tissues has been reported. Cancer is a multistep process involving several cell signalling pathways. These include the capacities to proliferate independently of exogenous growth-promoting signals, to invade surrounding tissues and metastasize to distant site sand to evade mechanisms that limit cell proliferation, such as apoptosis and replicative senescence. Membrane proteins are involved in the prognosis of the most common forms of cancer. Membrane proteins are the hallmark of a cancer cell. These overexpressed membrane receptors are becoming increasingly important in cancer cell therapy. Molecular oncology is an interdisciplinary medical specialty at the interface of medicinal chemistry and oncology that refers to the investigation of the chemistry of cancer and tumors at the molecular scale, involved in basic and translational cancer research on the cell and tissue level and bioinformatics developments in this area, and clinical applications.  In the social sciences and life sciences, a case study is an implementation of a research method involving an up-close, and detailed examination of a subject of study (the case), as well as its related contextual conditions.This Session Includes Molecular and cellular oncology, Cancer Genomics and Systems Biology, Metabolic complexity of signal transduction, Cancer stem cells, Case studies.For More Information please, CLICK HERE

  • Track 17-1Molecular and cellular oncology
  • Track 17-2Cancer Genomics and Systems Biology
  • Track 17-3Metabolic complexity of signal transduction
  • Track 17-4 Cancer stem cells
  • Track 17-5Case studies

For More Information please, CLICK HERE

  • Track 18-1Nurse Practitioner Education
  • Track 18-2Pschyatric Nurse Practitioner Education
  • Track 18-3Neonatal Nurse Practitioner Education
  • Track 18-4Family Nurse Practitioner Education

For More Information please, CLICK HERE

  • Track 19-1Licence Practice Cardiac nursing (LPN)
  • Track 19-2Evidence Based Practice in Nursing
  • Track 19-3Cardiac Registered Nursing (RN)

For More Information please, CLICK HERE

  • Track 20-1Online Nursing Programs
  • Track 20-2Online Nursing Schools
  • Track 20-3Advances in Online Nursing Classes

Radiation oncology is a medical specialty that involves treating cancer with radiation. Doctors who specialize in treating cancer with radiation (radiation oncologists) use radiation therapy to treat a wide variety of cancers. Radiation therapy uses carefully targeted and regulated doses of high-energy radiation to kill cancer cells. Radiation causes some cancer cells like in case of head and neck cancer or breast cancer  die immediately after treatment, but most die because the radiation damages the chromosomes and DNA so that the cells can no longer divide and the tumor can't grow.This Session Includes Radio sensitizers, Cellular Radiation Oncology, Molecular Radiation Oncology, Palliative radiotherapy, Radiation physics and Clinical Radiation Oncology .For More Information please, CLICK HERE

  • Track 21-1Radiosensitizers
  • Track 21-2Cellular Radiation Oncology
  • Track 21-3Molecular Radiation Oncology
  • Track 21-4Palliative radiotherapy
  • Track 21-5Radiation physics
  • Track 21-6Clinical Radiation Oncology
  • Track 21-7Chemotherapy